CE Mark Granted to Abbott’s Next-Generation Amulet 360 LAA Occluder

Abbott has received CE Mark approval for its Amulet 360 Left Atrial Appendage (LAA) Occluder, a next-generation device engineered to reduce stroke risk in patients living with non-valvular atrial fibrillation (AFib). The Amulet 360 CE Mark clearance marks the company’s fourth major electrophysiology approval in just over a year. First European Procedures Successfully Completed Following […]

The post CE Mark Granted to Abbott’s Next-Generation Amulet 360 LAA Occluder first appeared on HHM Global | B2B Online Platform & Magazine.